<DOC>
	<DOCNO>NCT00104078</DOCNO>
	<brief_summary>The purpose phase I/II , multicenter , safety trial study MYO-029 adult patient muscular dystrophy .</brief_summary>
	<brief_title>Study Evaluating MYO-029 Adult Muscular Dystrophy</brief_title>
	<detailed_description />
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Muscular Dystrophy , Facioscapulohumeral</mesh_term>
	<mesh_term>Muscular Dystrophies , Limb-Girdle</mesh_term>
	<criteria>Written inform consent . Confirmed clinical molecular diagnosis Becker Muscular Dystrophy ( BMD ) , Facioscapulohumeral Muscular Dystrophy ( FSHD ) , LimbGirdle Muscular Dystrophy ( LGMD ) Independently ambulatory Patients certain clinical condition Patients use steroid medication potential affect muscle function History sensitivity monoclonal antibody protein pharmaceutical Pregnant lactate woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2007</verification_date>
</DOC>